GN announced the issuance of an Interim Report for Q3 2020 for the following businesses:
GN Store Nord A/S
- During Q3 2020, GN was affected in two ways by COVID-19: (i) GN Audio experienced “strong demand as enterprises continued to invest in employees working from home,” and (ii) GN Hearing experienced “emerging recovery with continued impact from local restrictions,” according to the company’s announcement.
- Leverage of 2.2 times net interest-bearing debt to EBITDA.
- Operating in both the hearing aid and audio space, and with no forward integration, “is beneficial for GN during these challenging times.” GN delivered an EPS growth of 84% in Q3 2020 reaching DKK 4.78 (USD $.76), including gain from legal settlements and litigation, according to the company.
GN Store Nord
- GN delivered strong 29% organic revenue growth in Q3 2020,
- Free cash flow excluding M&A was DKK 612 million (USD $96.8 million) in Q3, reflecting the “strong growth,”
- The financial guidance for 2020, upgraded on October 9, 2020, is confirmed. Due to the COVID-19 situation, it must be stressed that the basic assumptions behind the guidance remain significantly more uncertain than normal, GN says.
- GN Hearing experienced “emerging recovery” with organic revenue growth of ‑11%, compared to an organic revenue growth of -54% in Q2 2020,
- Encouraging initial reception of ReSound ONE across all key markets with “positive launch feedback in a world still impacted by COVID-19,”
- EBITA was DKK 169 million (USD $26.7 million) in Q3 2020 compared to DKK 283 million (USD $44.7) in Q3 2019 due to the decline in revenue more than offsetting OPEX reductions,
- Free cash flow excluding M&A was DKK 47 million (USD $7.4 million) in Q3 2020 compared to DKK 289 million (USD $45.7 million)in Q3 2019, reflecting the “lower revenue level and channel investments,” according to GN.
- GN Audio experienced “outstanding 72% organic revenue growth in Q3 2020, driven by continued very strong demand for enterprise products combined with significant increase in production capacity,” GN said in its announcement. Furthermore, the consumer segment returned to “strong double-digit growth in the quarter.”
- EBITA increased by 129% to DKK 664 million (USD $105 million) (including gain from legal settlements and litigation of DKK 114 million (USD $18 million)) in Q3 2020 corresponding to an EBITA margin of 27.4%. The EBITA margin development reflects the gain from legal settlements and litigations and continuous leverage in the business offset by increased freight and production costs as a result of COVID-19, and investments in future growth opportunities.
- Free cash flow excluding M&A was DKK 592 million (USD $93.7 million) in Q3 2020 compared to DKK 329 million (USD $52 million) in Q3 2019, reflecting “the strong earnings growth and gain from legal settlements and litigation,” according to the company.
Gitte Aabo, CEO of GN Hearing, said: “Although we see short-term uncertainty due to the recent development in COVID-19 restrictions, we saw encouraging emerging recovery of the hearing aid market in Q3. I am pleased to see audiologists around the world getting their business back. Bringing ReSound ONE, as an entirely new class of hearing aids, to the market during these challenging times and receiving such positive reception and encouraging feedback shows us that innovative hearing technology is needed, now more than ever.”
René Svendsen-Tune, CEO of GN Audio, comments: “On the foundation of GN Audio’s distinctly leading product portfolio and our highly scalable business model, our teams and partners in Q3 delivered extraordinarily high sales growth. The demand was of course helped by the work-from-home agenda, but underneath we see a fundamentally sound development in demand for flexible solutions.”
Financial overview Q3 2020
|GN Hearing||GN Audio||GN Store Nord*|
|DKK million||Q3 2020||Q3 2019||Growth||Q3 2020||Q3 2019||Growth||Q3 2020||Q3 2019||Growth|
|Earnings per share (EPS) – DKK||4.78**||2.60||84%|
|Free cash flow excl. M&A||47||289||-242||592**||329||263||612**||563||49|
|* Including “Other” ** Including gain from legal settlements and litigation of DKK 114 million|